Published in J Med Microbiol on August 01, 2007
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrob Agents Chemother (2009) 2.41
Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res (2009) 2.24
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob Agents Chemother (2008) 2.13
National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol (2010) 2.10
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol (2012) 1.68
Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol (2008) 1.66
Multilocus sequence typing of pathogenic Candida species. Eukaryot Cell (2008) 1.27
Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev (2014) 1.21
Genetic diversity among Korean Candida albicans bloodstream isolates: assessment by multilocus sequence typing and restriction endonuclease analysis of genomic DNA by use of BssHII. J Clin Microbiol (2011) 1.20
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res (2012) 1.14
Candida albicans versus Candida dubliniensis: Why Is C. albicans More Pathogenic? Int J Microbiol (2011) 1.08
Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model. Eukaryot Cell (2009) 1.05
Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. FEMS Yeast Res (2009) 1.04
Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital. BMC Res Notes (2010) 1.02
Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. PLoS One (2012) 1.02
Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013. Clin Microbiol Infect (2015) 1.01
Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol (2012) 0.99
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata. Antimicrob Agents Chemother (2011) 0.99
Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies. Eukaryot Cell (2010) 0.97
Candida albicans forms a specialized "sexual" as well as "pathogenic" biofilm. Eukaryot Cell (2013) 0.93
Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis (2013) 0.91
Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment. J Clin Microbiol (2011) 0.88
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms. Antimicrob Agents Chemother (2013) 0.87
A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients. Front Microbiol (2016) 0.87
Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol (2014) 0.87
An observational study on the epidemiological and mycological profile of Candidemia in ICU patients. Med Sci Monit (2011) 0.86
Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. J Med Microbiol (2012) 0.85
Species and condition specific adaptation of the transcriptional landscapes in Candida albicans and Candida dubliniensis. BMC Genomics (2013) 0.85
Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil. Mem Inst Oswaldo Cruz (2013) 0.83
Candidemia surveillance in Brazil: evidence for a geographical boundary defining an area exhibiting an abatement of infections by Candida albicans group 2 strains. J Clin Microbiol (2010) 0.83
Discovery of the gray phenotype and white-gray-opaque tristable phenotypic transitions in Candida dubliniensis. Virulence (2015) 0.81
Particular Candida albicans strains in the digestive tract of dyspeptic patients, identified by multilocus sequence typing. PLoS One (2012) 0.81
Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil. J Clin Microbiol (2012) 0.80
Csr1/Zap1 Maintains Zinc Homeostasis and Influences Virulence in Candida dubliniensis but Is Not Coupled to Morphogenesis. Eukaryot Cell (2015) 0.80
Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study. Antimicrob Agents Chemother (2015) 0.78
Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014. PLoS One (2016) 0.77
The first Korean case of candidemia due to Candida dubliniensis. Ann Lab Med (2012) 0.77
Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital. PLoS One (2014) 0.77
Characterisation of the Candida albicans Phosphopantetheinyl Transferase Ppt2 as a Potential Antifungal Drug Target. PLoS One (2015) 0.75
Cohort Study: Central Venous Catheter-Related Complications in Children with Hematologic Diseases at a Single Center. Turk J Haematol (2015) 0.75
Total-Body Irradiation Exacerbates Dissemination of Cutaneous Candida Albicans Infection. Radiat Res (2016) 0.75
Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait. PLoS One (2017) 0.75
Intravenous Catheter-Associated Candidemia due to Candida membranaefaciens: The First Iranian Case. J Tehran Heart Cent (2015) 0.75
Multilocus sequence analyses reveal extensive diversity and multiple origins of fluconazole resistance in Candida tropicalis from tropical China. Sci Rep (2017) 0.75
Candida parapsilosis sensu lato in pediatric patients. Identification of cryptic species and antifungal susceptibility testing. Antimicrob Agents Chemother (2017) 0.75
Phenotypic diversity and correlation between white-opaque switching and the CAI microsatellite locus in Candida albicans. Curr Genet (2016) 0.75
eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol (2004) 17.92
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol (1994) 6.67
Guidelines for treatment of candidiasis. Clin Infect Dis (2003) 5.55
Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob Agents Chemother (1998) 4.95
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol (2004) 4.51
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis (2002) 4.35
Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol (2005) 3.93
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92
Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother (1994) 3.82
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis (2001) 3.75
Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis (2001) 3.68
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2005) 3.41
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol (2002) 3.30
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis (2004) 3.25
Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis (2004) 3.22
Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis (1999) 2.96
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol (2002) 2.94
Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model. Antimicrob Agents Chemother (1999) 2.67
National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis (1999) 2.63
Molecular phylogenetics of Candida albicans. Eukaryot Cell (2007) 2.41
Candida sepsis: pathogenesis and principles of treatments. Ann Surg (1974) 2.41
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev (2006) 2.39
Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect (2003) 2.29
Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species. Antimicrob Agents Chemother (2002) 2.26
Fungal flora of the normal human small and large intestine. N Engl J Med (1969) 2.25
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother (2002) 2.20
Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol (2003) 2.18
Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol (2003) 2.17
Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol (1999) 2.15
Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob Agents Chemother (1995) 2.07
Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol (2005) 2.04
Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol (2002) 1.92
Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis (2006) 1.89
Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa. J Clin Microbiol (2002) 1.81
Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade. J Clin Microbiol (2002) 1.80
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect (2003) 1.79
Epidemiology of candidemia. Rev Iberoam Micol (2000) 1.68
Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol (2005) 1.66
Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol (2006) 1.63
Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis (1998) 1.57
Candidemia in Finland, 1995-1999. Emerg Infect Dis (2003) 1.55
Candida albicans clades. FEMS Immunol Med Microbiol (2003) 1.55
Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol (2005) 1.52
Global trends in candidemia: review of reports from 1995-2005. Curr Infect Dis Rep (2005) 1.49
Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother (2005) 1.43
Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J Clin Microbiol (2006) 1.43
Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis (2005) 1.26
Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin Microbiol Infect (2005) 1.25
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagn Microbiol Infect Dis (2003) 1.06
Antifungal susceptibilities of Candida spp. isolated from blood in Spain and Argentina, 1996-1999. J Antimicrob Chemother (2002) 1.05
Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infect Control Hosp Epidemiol (2005) 1.03
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients. Br J Haematol (2002) 0.91
Candida dubliniensis at a university hospital in Saudi Arabia. J Clin Microbiol (2003) 0.86
Antifungal pharmacokinetics and pharmacodynamics: understanding the implications for antifungal drug resistance. Drug Resist Updat (2004) 0.84
Fatal Candida dubliniensis septicemia in a patient with AIDS. Clin Infect Dis (2005) 0.80
Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10
Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature (2009) 5.90
An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol (2008) 5.13
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest (2006) 4.45
Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol (2005) 3.93
Antifungal agents: mechanisms of action. Trends Microbiol (2003) 3.74
Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell (2004) 2.63
Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol (2008) 2.62
EST mining and functional expression assays identify extracellular effector proteins from the plant pathogen Phytophthora. Genome Res (2003) 2.57
Molecular phylogenetics of Candida albicans. Eukaryot Cell (2007) 2.41
Comparative genomics of the fungal pathogens Candida dubliniensis and Candida albicans. Genome Res (2009) 2.24
Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog (2008) 2.19
Optimization and validation of multilocus sequence typing for Candida albicans. J Clin Microbiol (2003) 2.18
Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell Microbiol (2006) 2.12
Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol (2005) 2.04
The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans. Mol Microbiol (2007) 2.00
Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans. J Biol Chem (2005) 1.95
Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol (2009) 1.93
Fungal echinocandin resistance. Fungal Genet Biol (2009) 1.78
The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol (2011) 1.76
Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. J Biol Chem (2005) 1.70
Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. Fungal Genet Biol (2008) 1.67
Comparative genomics of MAP kinase and calcium-calcineurin signalling components in plant and human pathogenic fungi. Fungal Genet Biol (2009) 1.66
Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. J Biol Chem (2004) 1.66
Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol (2005) 1.66
Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect Immun (2011) 1.54
Stage specific assessment of Candida albicans phagocytosis by macrophages identifies cell wall composition and morphogenesis as key determinants. PLoS Pathog (2012) 1.54
Glucose promotes stress resistance in the fungal pathogen Candida albicans. Mol Biol Cell (2009) 1.52
Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition. J Biol Chem (2004) 1.51
Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J Biol Chem (2008) 1.50
Infection-related gene expression in Candida albicans. Curr Opin Microbiol (2007) 1.50
Proteomic and phenotypic profiling of the amphibian pathogen Batrachochytrium dendrobatidis shows that genotype is linked to virulence. Mol Ecol (2009) 1.49
GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast (2004) 1.47
Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryot Cell (2007) 1.45
Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cell Microbiol (2012) 1.45
Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism. Curr Biol (2007) 1.43
Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol Microbiol (2003) 1.39
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob Agents Chemother (2010) 1.39
Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Genet Biol (2008) 1.37
Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans. J Infect Dis (2009) 1.37
Property differences among the four major Candida albicans strain clades. Eukaryot Cell (2009) 1.36
Genetic evidence for recombination in Candida albicans based on haplotype analysis. Fungal Genet Biol (2004) 1.33
Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol (2008) 1.33
Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One (2009) 1.31
Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. J Clin Microbiol (2006) 1.31
Chitin synthesis and fungal pathogenesis. Curr Opin Microbiol (2010) 1.30
Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction. Eukaryot Cell (2007) 1.29
Multilocus sequence typing of pathogenic Candida species. Eukaryot Cell (2008) 1.27
Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog (2013) 1.27
Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob Agents Chemother (2011) 1.25
Toll-like receptor 9-dependent activation of myeloid dendritic cells by Deoxynucleic acids from Candida albicans. Infect Immun (2009) 1.22
Stress adaptation in a pathogenic fungus. J Exp Biol (2014) 1.21
Non-lytic expulsion/exocytosis of Candida albicans from macrophages. Fungal Genet Biol (2012) 1.18
Asynchronous cell cycle and asymmetric vacuolar inheritance in true hyphae of Candida albicans. Eukaryot Cell (2003) 1.18
Homologous recombination in Candida albicans: role of CaRad52p in DNA repair, integration of linear DNA fragments and telomere length. Mol Microbiol (2004) 1.17
CO(2) acts as a signalling molecule in populations of the fungal pathogen Candida albicans. PLoS Pathog (2010) 1.15
Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. J Antimicrob Chemother (2005) 1.13
Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling. Med Mycol (2011) 1.12
Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. Clin Vaccine Immunol (2014) 1.11
Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob Agents Chemother (2012) 1.11
Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol Lett (2008) 1.11
Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors. Med Mycol (2010) 1.10
An internal polarity landmark is important for externally induced hyphal behaviors in Candida albicans. Eukaryot Cell (2008) 1.10
Global role of the protein kinase Gcn2 in the human pathogen Candida albicans. Eukaryot Cell (2005) 1.09
CHS8-a fourth chitin synthase gene of Candida albicans contributes to in vitro chitin synthase activity, but is dispensable for growth. Fungal Genet Biol (2003) 1.09
The evolutionary rewiring of ubiquitination targets has reprogrammed the regulation of carbon assimilation in the pathogenic yeast Candida albicans. MBio (2012) 1.08
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother (2005) 1.08
Mechanisms of hypha orientation of fungi. Curr Opin Microbiol (2009) 1.08
Candida albicans Iff11, a secreted protein required for cell wall structure and virulence. Infect Immun (2007) 1.07
Individual chitin synthase enzymes synthesize microfibrils of differing structure at specific locations in the Candida albicans cell wall. Mol Microbiol (2007) 1.07
A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. J Biol Chem (2010) 1.04
Internuclear gene silencing in Phytophthora infestans is established through chromatin remodelling. Microbiology (2008) 1.04
Combinatorial stresses kill pathogenic Candida species. Med Mycol (2012) 1.03
Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists. Biochemistry (2008) 1.02
Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008. Emerg Infect Dis (2011) 0.99
Role of Dectin-2 for host defense against systemic infection with Candida glabrata. Infect Immun (2013) 0.99
The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans. PLoS Pathog (2013) 0.99
Predicting the public health benefit of vaccinating cattle against Escherichia coli O157. Proc Natl Acad Sci U S A (2013) 0.99
Independent regulation of chitin synthase and chitinase activity in Candida albicans and Saccharomyces cerevisiae. Microbiology (2004) 0.99
Mannosylation in Candida albicans: role in cell wall function and immune recognition. Mol Microbiol (2013) 0.97
Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface. Microbiology (2009) 0.97
Vacuoles and fungal biology. Curr Opin Microbiol (2008) 0.96
Calcium homeostasis is required for contact-dependent helical and sinusoidal tip growth in Candida albicans hyphae. Mol Microbiol (2009) 0.95
Gene flow in environmental Legionella pneumophila leads to genetic and pathogenic heterogeneity within a Legionnaires' disease outbreak. Genome Biol (2014) 0.95
Interactions between macrophages and cell wall oligosaccharides of Candida albicans. Methods Mol Biol (2012) 0.94
Melanin externalization in Candida albicans depends on cell wall chitin structures. Eukaryot Cell (2010) 0.93
Candida albicans cell wall glycosylation may be indirectly required for activation of epithelial cell proinflammatory responses. Infect Immun (2011) 0.93
Candida albicans infection inhibits macrophage cell division and proliferation. Fungal Genet Biol (2012) 0.93
Pathogenic potential to humans of bovine Escherichia coli O26, Scotland. Emerg Infect Dis (2012) 0.93
Potassium homeostasis influences the locomotion and encystment of zoospores of plant pathogenic oomycetes. Fungal Genet Biol (2005) 0.91
Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans. Microbiology (2010) 0.91
Vacuole inheritance regulates cell size and branching frequency of Candida albicans hyphae. Mol Microbiol (2008) 0.91
Candida albicans primes TLR cytokine responses through a Dectin-1/Raf-1-mediated pathway. J Immunol (2013) 0.89
Sex- and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions. Brain Res (2006) 0.89